DMAA
Drugs Made In America Acquisition Corp.
10.90$
+0.1%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -190.8% | – | – | – | |
| – | – | +3.7% | -121.3% | – | – | -171.7% | – | -588.3% | – | |
| – | – | – | +0.0% | -100.0% | – | -100.0% | – | – | – | |
| – | – | – | – | +0.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -100.0% | – | – | – | +150.0% | – | |
| – | +30,889.3% | -101.5% | – | +0.0% | -199.9% | – | -23.4% | -98,561.2% | – | |
| – | -88,514.4% | – | – | – | – | – | +61.4% | -38.4% | – | |
| – | – | – | – | – | – | -190.8% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.